Hormonal
Tirzepatide 15 mg once weekly produces significantly greater fat mass reduction and total body weight loss compared to semaglutide 1 mg and placebo in people with type 2 diabetes, primarily driven by fat mass rather than fat-free mass changes.
If you have type 2 diabetes, tirzepatide 15 mg taken once weekly is more effective than semaglutide 1 mg for reducing body fat and total weight. The weight loss comes mainly from fat, preserving muscle mass better than placebo. This suggests that for T2D patients seeking significant fat loss, tirzepatide may be a superior pharmacological option to semaglutide.
Tirzepatide treatment demonstrated significant reductions in body weight compared with placebo and semaglutide, resulting in greater fat mass reduction... Body weight loss with tirzepatide was predominantly driven by fat mass reduction.
Why this rating
Randomized, double-blind, parallel-arm study with statistical significance, though sample size was not explicitly powered for secondary outcomes.
Source
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Tim Heise et al. · Diabetes Care · 2023
DOI 10.2337/dc22-1710
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →